# US 2020/0262873 A1 · Immunoglobulin binding protein, and affinity support using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0262873 A1
- Document ID: US20200262873A1
- Status: Published application
- Kind: A1
- Application number: 16/649,889
- Filed: 2018-09-25
- Published: 2020-08-20
- Earliest claimed: 2017-09-25
- Assignees: Jsr Corporation; Jsr Life Sciences Corporation; JSR Micro N.V.
- Applicants: Jsr Corporation; JSR Life Sciences Corporation; JSR Micro Inc.; JSR Micro N.V.
- Inventors: Jun-ichi YASUOKA; Kiichi YOSHIMURA; Tomoaki HAGA
- Web page: https://patentgrep.com/patent/US20200262873A1

## CPC

- B01D 15/3804: {Affinity chromatography}
- B01D 15/3809: {of the antigen-antibody type, e.g. protein A, G or L chromatography}
- B01J 20/24: Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
- B01J 20/288: Polar phases
- B01J 20/3085: {Chemical treatments not covered by groups B01J20/3007 - B01J20/3078}
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K 14/195: from bacteria
- C12N 5/10: Cells modified by introduction of foreign genetic material
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- B01J 2220/52: Sorbents specially adapted for preparative chromatography
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided are a protein L-derived immunoglobulin binding protein having an increased antibody dissociation rate under acidic conditions, and an affinity support using the same. Disclosed are an immunoglobulin binding protein comprising at least one mutant of an immunoglobulin binding domain, and an affinity support comprising a solid-phase support having the immunoglobulin binding protein bound thereto. A mutant of the immunoglobulin binding domain consists of an amino acid sequence having an identity of at least 85% with the sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9 and a predetermined mutation, and the mutant has immunoglobulin κ chain binding activity.

## Claims

### Claim 1

An immunoglobulin binding protein, comprising at least one mutant of an immunoglobulin binding domain,
wherein the mutant of the immunoglobulin binding domain consists of an amino acid sequence having an identity of at least 85% with the sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9, the amino acid sequence having at least one mutation selected from the group consisting of the following (a) to (n), and the mutant has immunoglobulin κ chain binding activity:
(a) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 16th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(b) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 18th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(c) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 20th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(d) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 26th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(e) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 28th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(f) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 30th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(g) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 32th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(h) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 34th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(i) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 35th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(j) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 38th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(k) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 42th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(l) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 54th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(m) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 57th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position; and
(n) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 70th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position.

### Claim 2 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein
the mutation of the (a) is substitution of an amino acid residue at a position corresponding to the 16th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue, the mutation of the (b) is substitution of an amino acid residue at a position corresponding to the 18th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (c) is substitution of an amino acid residue at a position corresponding to the 20th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (d) is substitution of an amino acid residue at a position corresponding to the 26th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (e) is substitution of an amino acid residue at a position corresponding to the 28th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (f) is substitution of an amino acid residue at a position corresponding to the 30th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (g) is substitution of an amino acid residue at a position corresponding to the 32th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (h) is substitution of an amino acid residue at a position corresponding to the 34th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (i) is substitution of an amino acid residue at a position corresponding to the 35th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (j) is substitution of an amino acid residue at a position corresponding to the 38th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (k) is substitution of an amino acid residue at a position corresponding to the 42th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (l) is substitution of an amino acid residue at a position corresponding to the 54th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue,
the mutation of the (m) is substitution of an amino acid residue at a position corresponding to the 57th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue, and
the mutation of the (n) is substitution of an amino acid residue at a position corresponding to the 70th-position of the amino acid sequence set forth in SEQ ID NO:9 with another amino acid residue.

### Claim 3 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein the another amino acid residue is Gln, Asp, Lys, Arg, or His.

### Claim 4 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein the mutant of the immunoglobulin binding domain consists of an amino acid sequence having an identity of at least 85% with the sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9 and having an amino acid residue selected from Gln, Asp, Lys, Arg, or His at at least one position selected from the group consisting of positions corresponding to the 16th-position, 18th-position, 20th-position, 26th-position, 28th-position, 30th-position, 32th-position, 34th-position, 35th-position, 38th-position, 42th-position, 54th-position, 57th-position, and 70th-position of the amino acid sequence set forth in SEQ ID NO:9.

### Claim 5 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein the mutant of the immunoglobulin binding domain consists of an amino acid sequence having an identity of at least 85% with the amino acid sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9 and having any one of the following (a′) to (q′):
(a′) His at a position corresponding to the 16th-position of the amino acid sequence set forth in SEQ ID NO:9;
(b′) His at a position corresponding to the 18th-position of the amino acid sequence set forth in SEQ ID NO:9;
(c′) His at a position corresponding to the 20th-position of the amino acid sequence set forth in SEQ ID NO:9;
(d′) Arg at a position corresponding to the 26th-position of the amino acid sequence set forth in SEQ ID NO:9;
(e′) His at a position corresponding to the 28th-position of the amino acid sequence set forth in SEQ ID NO:9;
(f′) His at a position corresponding to the 30th-position of the amino acid sequence set forth in SEQ ID NO:9;
(g′) His at a position corresponding to the 32th-position of the amino acid sequence set forth in SEQ ID NO:9;
(h′) His at a position corresponding to the 34th-position of the amino acid sequence set forth in SEQ ID NO:9;
(i′) Arg at a position corresponding to the 35th-position of the amino acid sequence set forth in SEQ ID NO:9;
(j′) Lys at a position corresponding to the 38th-position of the amino acid sequence set forth in SEQ ID NO:9;
(k′) Lys at a position corresponding to the 42th-position of the amino acid sequence set forth in SEQ ID NO:9;
(l′) Gln at a position corresponding to the 54th-position of the amino acid sequence set forth in SEQ ID NO:9;
(m′) His at a position corresponding to the 57th-position of the amino acid sequence set forth in SEQ ID NO:9;
(n′) His at a position corresponding to the 70th-position of the amino acid sequence set forth in SEQ ID NO:9;
(o′) a combination of the (d′), (h′), (i′), (k′), and (l′);
(p′) a combination of the (d′), (i′), (k′), (l′), and (m′); and
(q′) a combination of the (d′), (g′), (i′), (k′), and (l′).

### Claim 6 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein the amino acid sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9 is an amino acid sequence set forth in SEQ ID NO:9.

### Claim 7 (depends on 1)

The immunoglobulin binding protein according to claim 1, wherein the identity of at least 85% is an identity of at least 90%.

### Claim 8 (depends on 1)

The immunoglobulin binding protein according to claim 1, comprising two or more of the mutants of the immunoglobulin binding domain.

### Claim 9 (depends on 1)

A polynucleotide encoding the immunoglobulin binding protein according to claim 1.

### Claim 10 (depends on 9)

A vector, comprising the polynucleotide according to claim 9.

### Claim 11 (depends on 10)

A transformant, comprising the vector according to claim 10.

### Claim 12 (depends on 1)

An affinity support, comprising a solid-phase support; and the immunoglobulin binding protein according to claim 1 bound to the solid-phase support.

### Claim 13 (depends on 12)

A method ,comprising:
isolating an antibody or a fragment thereof, the method comprising using with the affinity support according to claim 12.

### Claim 14 (depends on 1)

A method for producing an immunoglobulin binding protein, the method comprising:
expressing the immunoglobulin binding protein according to claim 1 in a transformant comprising a vector comprising a polynucleotide encoding the immunoglobulin binding protein or a cell-free protein synthesis system, or chemically synthesizing the immunoglobulin binding protein.

### Claim 15

A method for producing a mutant of an immunoglobulin binding domain, the method comprising:
introducing at least one mutation selected from the group consisting of the following (a) to (n) to a polypeptide consisting of an amino acid sequence set forth in any one of SEQ ID NO:1 to SEQ ID NO:9 or an amino acid sequence having an identity of at least 85% therewith, the polypeptide having immunoglobulin x chain binding activity:
(a) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 16th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(b) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 18th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(c) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 20th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(d) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 26th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(e) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 28th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(f) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 30th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(g) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 32th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(h) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 34th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(i) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 35th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(j) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 38th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(k) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 42th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(l) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 54th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position;
(m) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 57th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position; and
(n) substitution with another amino acid residue or deletion of an amino acid residue at a position corresponding to the 70th-position of the amino acid sequence set forth in SEQ ID NO:9, or insertion of an amino acid residue into a position in front of or behind the relevant position.

### Claim 16 (depends on 1)

A method for producing an affinity support, the method comprising:
immobilizing the immunoglobulin binding protein according to claim 1 on a solid-phase support.
